FDA Chief Counsel Addresses Staff Turnover, Device Bans
This article was originally published in The Gray Sheet
Staff turnover in FDA's Office of the Chief Counsel is a positive, says the agency's top lawyer Elizabeth Dickinson. The chief counsel also discussed recent device bans, off-label communication policy efforts and the agency’s ongoing transparency initiative at the annual Food & Drug Law Institute conference.
Register for our free email digests: